13THIRTY CANCER CONNECT INC

Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$1,111,122
Investments
77%
Cash & Equivalents
13%
Other Assets
8%
Property, Plant, & Equipment (net)
2%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Liabilities in 2024 (Year End)
$225,118
Notes Payable / Debt (Non-Related)
62%
Other Liabilities
37%
Payables & Accruals
1%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$229,251
$148,490
-35%
Receivables (Non-Related)
-
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
-
-
-
Investments
$806,005
$852,546
+6%
Property, Plant, & Equipment (net)
$38,940
$25,945
-33%
Other Assets
$39,159
$84,141
+115%
Total Assets
$1,113,355
$1,111,122
0%
Liabilities
2023
2024
Change
Payables & Accruals
$6,243
$2,944
-53%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$138,700
$138,700
+0%
Related-Party Payables
-
-
-
Other Liabilities
$37,526
$83,474
+122%
Total Liabilities
$182,469
$225,118
+23%
Net assets
2023
2024
Change
Restricted Net Assets
$13,500
$13,500
+0%
Unrestricted Net Assets
$917,386
$872,504
-5%
Net assets
2023
2024
Change
Net assets
+$930,886
+$886,004
-5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)